Comparative costs of home positive inotropic infusion versus in-hospital care in patients awaiting cardiac transplantation

Journal of Cardiac Failure

Volumn 10, Issue 5, 2004, Pages 384-389

  Upadya, Shrikanth P Y ^a,b   Sedrakyan, Artyom ^a,b   Saldarriaga, Clara ^a,b   Nystrom, Karin ^a,b   Bozzo, Janis ^a,b   Lee, Forrester A ^a,b   Katz, Stuart D ^a,b  

^a Section of Cardiovascular Medicine ^*

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Health care costs; Heart failure; Positive intropic agents

Indexed keywords

DOBUTAMINE; MILRINONE; CARDIOTONIC AGENT;

ARTICLE; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; COST MINIMIZATION ANALYSIS; DECISION MAKING; DEFIBRILLATOR; HEALTH CARE COST; HEART TRANSPLANTATION; HOME CARE; HOSPITAL CARE; HUMAN; INOTROPISM; PRIORITY JOURNAL; TREATMENT OUTCOME; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DECISION SUPPORT SYSTEM; ECONOMICS; HOSPITALIZATION; INFUSION; OUTCOME ASSESSMENT;

CARDIOTONIC AGENTS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HOME INFUSION THERAPY; HOSPITALIZATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 21644456647     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2004.02.004     Document Type: Article

References (17)

1. Renlund DG, Taylor DO, Kfoury AG, Shaddy RS. New UNOS rules: historical background and implications for transplantation management. United Network for Organ Sharing. J Heart Lung Transplant 1999;18:1065-70.
2. 2000 Annual Report: The US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network, transplant data 1990-1999. Washington, DC: Department of Health and Human Services; 2000. p. 42-4.
3. Upadya S, Lee FA, Saldarigga C, Verma S, Sedrakyan A, Nystrom K, et al. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure. J Heart Lung Transplant 2004;23:466-72.
4. Lang CC, Hankins S, Hauff H, Maybaum S, Edwards N, Mancini DM. Morbidity and mortality of UNOS status IB cardiac transplant candidates at home. J Heart Lung Transplant 2003;22:419-26.
5. Hodgson JM, Aja M, Sorkin RP. Intermittent ambulatory dobutamine infusions for patients awaiting cardiac transplantation. Am J Cardiol 1984;53:375-6.
6. Miller LW, Merkle EJ, Herrmann V. Outpatient dobutamine for endstage congestive heart failure. Crit Care Med 1990;18:S30-3.
7. Miller LW, Merkle EJ, Jennison SH. Outpatient use of dobutamine to support patients awaiting heart transplantation. J Heart Lung Transplant 1994;13:S126-9.
8. Applefeld MM, Newman KA, Sutton FJ, Reed WP, Roffman DS, Talesnick BS, et al. Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients. Am Heart J 1987;114:589-95.
9. Erlemeier HH, Kupper W, Bleifeld W. Intermittent infusion of dobutamine in the therapy of severe congestive heart failure-long-term effects and lack of tolerance. Cardiovasc Drugs Ther 1992;6:391-8.
10. Sindone AP, Keogh AM, Macdonald PS, McCosker CJ, Kaan AF. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy. Am Heart J 1997;134:889-900.
11. Harjai KJ, Mehra MR, Ventura HO, Lapeyre YM, Murgo JP, Stapleton DD, et al. Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes. Chest 1997;112:1298-303.
12. Marius-Nunez AL, Heaney L, Fernandez RN, Clark WA, Ranganini A, Silber E, et al. Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure. Am Heart J 1996;132:805-8.
13. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346: 877-83.
14. Sandner SE, Wieselthaler G, Zuckermann A, Taghavi S, Schmidinger H, Fächer R, et al. Survival benefit of the implantable cardioverter- defibrillator in patients on the waiting list for cardiac transplantation. Circulation 2001; 104:1171-6.
15. Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol 2004;27:4-9.
16. Katz SD. Nesiritide (hBNP): a new class of therapeutic peptide for the treatment of decompensated congestive heart failure. Congest Heart Fail 2001;7:78-87.
17. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.